Ole Christian Lingjærde

Ole Christian Lingjærde

Auto-generated profile, based on publicly available information

Ole Christian Lingjærde

Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, P.O. Box 4953 Nydalen, N-0424 Oslo, Norway

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
PLPeter Van Loo
Peter Van Loo
SNSilje H. Nordgard
Silje H. Nordgard
OLOle Christian Lingjærde
Ole Christian Lingjærde
HRHege G. Russnes
Hege G. Russnes
IRInga H. Rye
Inga H. Rye
VKVessela N. Kristensen
Vessela N. Kristensen
We present an allele-specific copy number analysis of the in vivo breast cancer genome. We describe a unique bioinformatics approach, ASCAT (allele-specific copy number analysis of tumors), to accurately dissect the allele-specific copy number of solid tumors, simultaneously estimating and adjusting for both tumor ploidy and nonaberrant cell admixture. This allows calculation of “ASCAT profiles” (genome-wide allele-specific copy-number profiles) from which gains, losses, copy number-neutral events, and loss of heterozygosity (LOH) can accurately be determined. In an early-stage breast carcinoma series, we observe aneuploidy (>2.7n) in 45% of the cases and an average nonaberrant cell admixture of 49%. By aggregation of ASCAT profiles across our series, we obtain genomic frequency distributions of gains and losses, as well as genome-wide views of LOH and copy number-neutral events in breast cancer. In addition, the ASCAT profiles reveal differences in aberrant tumor cell fraction, ploidy, gains, losses, LOH, and copy number-neutral events between the five previously identified molecular breast cancer subtypes. Basal-like breast carcinomas have a significantly higher frequency of LOH compared with other subtypes, and their ASCAT profiles show large-scale loss of genomic material during tumor development, followed by a whole-genome duplication, resulting in near-triploid genomes. Finally, from the ASCAT profiles, we construct a genome-wide map of allelic skewness in breast cancer, indicating loci where one allele is preferentially lost, whereas the other allele is preferentially gained. We hypothesize that these alternative alleles have a different influence on breast carcinoma development.

24 April 2014 in Nature Reviews Cancer
Verified
Journal Article
Closed access
VKVessela N. Kristensen
Vessela N. Kristensen
OLOle Christian Lingjærde
Ole Christian Lingjærde
HRHege G. Russnes
Hege G. Russnes
HVHans Kristian M. Vollan
Hans Kristian M. Vollan
AFArnoldo Frigessi
Arnoldo Frigessi
ABAnne-Lise Børresen-Dale
Anne-Lise Børresen-Dale

4 November 2012 in BMC Genomics
Verified
Journal Article
Open access
PDF file
GNGro Nilsen
Gro Nilsen
KLKnut Liestøl
Knut Liestøl
PLPeter Van Loo
Peter Van Loo
HVHans Kristian Moen Vollan
Hans Kristian Moen Vollan
MEMarianne B Eide
Marianne B Eide
OLOle Christian Lingjærde
Ole Christian Lingjærde
Background: Cancer progression is associated with genomic instability and an accumulation of gains and losses of DNA. The growing variety of tools for measuring genomic copy numbers, including various types of array-CGH, SNP arrays and high-throughput sequencing, calls for a coherent framework offering unified and consistent handling of single- and multi-track segmentation problems. In addition, there is a demand for highly computationally efficient segmentation algorithms, due to the emergence of very high density scans of copy number. Results: A comprehensive Bioconductor package for copy number analysis is presented. The package offers a unified framework for single sample, multi-sample and multi-track segmentation and is based on statistically sound penalized least squares principles. Conditional on the number of breakpoints, the estimates are optimal in the least squares sense. A novel and computationally highly efficient algorithm is proposed that utilizes vector-based operations in R. Three case studies are presented. Conclusions: The R package is a software suite for segmentation of single- and multi-track copy number data using algorithms based on coherent least squares principles.

6 June 2007 in Bioinformatics
Verified
Journal Article
Open access
PDF file
HBH.M. Bøvelstad
H.M. Bøvelstad
Ståle NygårdStåle Nygård
Ståle Nygård
HSH.L. Størvold
H.L. Størvold
MAMagne Aldrin
Magne Aldrin
ØBØ. Borgan
Ø. Borgan
OLO.C. Lingjærde
O.C. Lingjærde
Motivation: Survival prediction from gene expression data and other high-dimensional genomic data has been subject to much research during the last years. These kinds of data are associated with the methodological problem of having many more gene expression values than individuals. In addition, the responses are censored survival times. Most of the proposed methods handle this by using Cox's proportional hazards model and obtain parameter estimates by some dimension reduction or parameter shrinkage estimation technique. Using three well-known microarray gene expression data sets, we compare the prediction performance of seven such methods: univariate selection, forward stepwise selection, principal components regression (PCR), supervised principal components regression, partial least squares regression (PLS), ridge regression and the lasso. Results: Statistical learning from subsets should be repeated several times in order to get a fair comparison between methods. Methods using coefficient shrinkage or linear combinations of the gene expression values have much better performance than the simple variable selection methods. For our data sets, ridge regression has the overall best performance. Availability: Matlab and R code for the prediction methods are available at http://www.med.uio.no/imb/stat/bmms/software/microsurv/. Contact:hegembo@math.uio.no

5 November 2004 in Bioinformatics
Verified
Journal Article
Closed access
OLOle Christian Lingjærde
Ole Christian Lingjærde
LBLars O. Baumbusch
Lars O. Baumbusch
KLKnut Liestøl
Knut Liestøl
IGIngrid K. Glad
Ingrid K. Glad
ABAnne-Lise Børresen-Dale
Anne-Lise Børresen-Dale
Summary: CGH-Explorer is a program for visualization and statistical analysis of microarray-based comparative genomic hybridization (array-CGH) data. The program has preprocessing facilities, tools for graphical exploration of individual arrays or groups of arrays, and tools for statistical identification of regions of amplification and deletion. Availability: The program is available as Java class files that runs on any platform with the Java 2 runtime environment (J2SE JRE) installed, and as a Windows executable. Java source files are also available. See http://www.ifi.uio.no/bioinf/Papers/CGH/ Contact: ole@ifi.uio.no

8 April 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
HJHenrik J. Johansson
Henrik J. Johansson
FSFabio Socciarelli
Fabio Socciarelli
NVNathaniel M. Vacanti
Nathaniel M. Vacanti
MHMads H. Haugen
Mads H. Haugen
YZYafeng Zhu
Yafeng Zhu
JLJanne Lehtiö
Janne Lehtiö
In the preceding decades, molecular characterization has revolutionized breast cancer (BC) research and therapeutic approaches. Presented herein, an unbiased analysis of breast tumor proteomes, inclusive of 9995 proteins quantified across all tumors, for the first time recapitulates BC subtypes. Additionally, poor-prognosis basal-like and luminal B tumors are further subdivided by immune component infiltration, suggesting the current classification is incomplete. Proteome-based networks distinguish functional protein modules for breast tumor groups, with co-expression of EGFR and MET marking ductal carcinoma in situ regions of normal-like tumors and lending to a more accurate classification of this poorly defined subtype. Genes included within prognostic mRNA panels have significantly higher than average mRNA-protein correlations, and gene copy number alterations are dampened at the protein-level; underscoring the value of proteome quantification for prognostication and phenotypic classification. Furthermore, protein products mapping to non-coding genomic regions are identified; highlighting a potential new class of tumor-specific immunotherapeutic targets.